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liferating cell nuclear antigen (PCNA), which suggests
that cell replication plays an important role in restenosis
lesion formation. In contrast, other study results showed
low-level expression of PCNA in coronary atherectomy
tissues after stent implantation.8 Further, experimental
study with rabbit iliac arteries suggested that accumulation
of ECM was critical for post-stenting lesion growth.9 One
possible explanation for these results is that heterogenous
findings coexist in the same lesion. If the previous concept
is correct, a variety of findings should be observed, depen-
dent on the sampling method. In stent-implanted arteries,
the stent itself potently induces inflammatory infiltra-
tion,9,10 and this reaction might promote local pathologic
changes around the stent struts in addition to the findings
caused by dilation angioplasty. We therefore think that
whole arterial samples in which a stent has been implanted
have to be analyzed to understand the true mechanisms of
in-stent lesion formation. In this study, we evaluated the
pathogenetic heterogeneity of in-stent intimal lesions with
five stent-implanted peripheral arteries that were surgically
resected.
MATERIALS AND METHODS
Patients. Five consecutive series of retrieved whole
arterial specimens in which a stent had been implanted
were examined in this study. These arterial samples were
Intimal hyperplasia is thought to be important in the
formation of in-stent restenosis after vascular stent implan-
tation, but the mechanism of development of in-stent
lesions is poorly understood.1 Previous studies with exper-
imental animal models of arterial injury showed that the
formation of intimal hyperplasia consists of three
processes: cell replication, cell migration, and accumula-
tion of extracellular matrix (ECM) in the arterial wall.2-4
However, clinical reports regarding how these factors con-
tribute to in-stent lesion formation are still limited,5-8 and
there is discrepancy between the findings of these studies.
In peripheral atherosclerotic lesions after stent implanta-
tion, Kearney et al7 reported abundant expression of pro-
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Purpose: Intimal hyperplasia is known to promote in-stent restenosis after vascular stent implantation. Although previ-
ous studies have presented a variety of evidence that suggests the mechanisms of intimal lesion formation, it is still con-
troversial which factor(s) predominantly contribute to the development of in-stent restenosis. In this study, we
hypothesized that heterogenous mechanisms coexist in the same lesion and then assessed the validity with resected
whole arteries with in-stent lesions.
Methods: Whole arterial specimens with in-stent lesions were surgically resected from five patients who had undergone
implantation of a Palmaz-Schatz stent 7 to 19 months previously and were histologically analyzed. For assessment of
the pathogenetic heterogeneity of in-stent lesions, we divided each cross section into three parts: the inner intima within
250 m from the luminal surface (zone A), the area surrounding the stent struts within 250 m from the strut hole
(zone B), and the remaining part of the intimal layer (zone C). We then evaluated cell density, cell replication, and cel-
lular composition in each zone. Cell replication and cellular composition were analyzed with immunohistologic stain-
ing with antibodies against proliferating cell nuclear antigen and cell-specific antibodies. Each section was also stained
with Alcian blue or Elastica van Gieson method for detection of matrix components.
Results: In all samples, the cell density of zone A was significantly higher than that of zone B (P < .05). Proliferating
cell nuclear antigen staining results showed significantly higher cell replication in zone A as compared with that in other
zones (P < .05). To the contrary, cell-specific immunostaining results revealed marked accumulation of leukocytes,
macrophages, and T lymphocytes in zone B (P < .05). Regarding matrix components, proteoglycan was predominantly
stained around stent struts and in the inner intima.
Conclusion: The data of this study showed that two different pathogenetic processes in different zones possibly con-
tributed to in-stent lesion formation at the same time. One process was an increase of cell number in the inner intima,
which was the result of a prolonged increase of cell replication. The other process was accumulation of matrix around
stent struts, which was suggested to be linked to infiltration of inflammatory cells in the same zone. (J Vasc Surg
2002;35:672-8.)
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surgically resected from five patients who had undergone
implantation of a Palmaz-Schatz stent (Cordis, Warren,
NJ) for chronic arterial occlusive disease 7 to 19 months
previously. Two samples were from the external iliac
artery, one was from the common iliac artery, and two
were from the superficial femoral artery. The details of the
patients are shown in Table I. Operation was performed
for severe in-stent restenosis in four cases (Table I; patients
2, 3, 4, and 5) and in one case (Table I; patient 1) for
repair of an anastomotic aneurysm that occurred near the
site where the stent was implanted. None of the in-stent
lesions was treated with additional angioplasty, atherec-
tomy, or other procedures until the operation, and no
stent-implanted segments were occluded. After the
removal of arterial specimens, bypass operation with pros-
thetic vascular grafts was carried out for arterial recon-
struction. 
Measurement of cell density. The stent-implanted
arterial samples were opened longitudinally, and three
short segments were randomly cut from the middle sec-
tion that was 5 mm from the edge of the stent. In this
manipulation, the sample segments were cut thinly so as
not to contain the crossing part of stent struts.
Subsequently, fragments of stent struts were gently
removed from the sample segments, as if a splinter were
picked out. Because there was no crossing part of stent
struts in the sample, sample damage with strut removal
was minimized. The previous procedures were carried out
with a stereoscopic microscope. The arterial sample seg-
ments were fixed in 4% phosphate-buffered paraformalde-
hyde (0.1 mol/L PO4 buffer; pH, 7.3) overnight11 and
embedded in paraffin for histologic analysis. Then, 4-m
sections were cut from each paraffin block and stained
with hematoxylin and eosin. In each section, cell density
was measured in three areas: the inner intima within 250
m from the luminal surface (zone A), the area surround-
ing stent struts within 250 m from the strut hole (zone
B), and the remaining part of the intimal layer (zone C;
Table I. Clinical profiles of five patients with in-stent restenosis and cell density data
Cell density (103/mm2)Age Interval Stent 
Patient Sex (years) Site (months) size (mm) Zone A* Zone B Zone C
1 M 75 EIA 8 7 2.4 ± 0.6 1.9 ± 0.4 2.0 ± 0.4
2 M 76 SFA 12 6 2.2 ± 0.6 1.6 ± 0.2 1.7 ± 0.4
3 M 60 SFA 7 6 2.1 ± 0.4 1.6 ± 0.3 1.7 ± 0.3
4 M 65 EIA 8 7 2.0 ± 0.4 1.6 ± 0.3 1.7 ± 0.3
5 M 60 CIA 19 7 1.8 ± 0.3 1.5 ± 0.3 1.5 ± 0.3
Total 2.1 ± 0.5 1.7 ± 0.3 1.8 ± 0.4
Values are shown as mean ± standard deviation. Cell density of zones A, B, and C was analyzed in each case. Total is average of five specimens.
*P < .05 versus zone B.
M, Male; EIA, external iliac artery; SFA, superficial femoral artery; CIA, common iliac artery.
Table II. Antigen-positive cell index of proliferating cell nuclear antigen, macrophage, leukocyte common antigen,
T lymphocyte, and von Willebrand’s factor
Patient Zone PCNA (+) Macrophage(+) LCA(+) T lymphocyte(+) vWF(+)
1 A 8.0 ± 3.6* 0.8 ± 0.8 1.8 ± 1.0 1.1 ± 0.8 0.1 ± 0.3
B 2.2 ± 1.3 9.7 ± 4.5* 4.4 ± 2.5* 3.3 ± 2.4* 1.7 ± 1.6*
C 1.1 ± 1.1 0.8 ± 0.6 1.1 ± 1.0 0.8 ± 0.9 0.1 ± 0.3
2 A 6.1 ± 1.8* 0.5 ± 0.7 0.9 ± 1.0 0.6 ± 0.8 0.1 ± 0.3
B 1.8 ± 1.4 5.3 ± 3.5* 4.3 ± 2.4* 3.4 ± 2.1* 2.0 ± 1.6*
C 0.9 ± 0.9 0.7 ± 0.9 0.7 ± 1.0 0.5 ± 0.7 0.1 ± 0.3
3 A 6.1 ± 2.8* 0.4 ± 0.5 0.9 ± 1.2 1.1 ± 1.1 0.1 ± 0.2
B 2.6 ± 1.0 3.0 ± 2.1* 5.2 ± 4.0* 4.0 ± 3.4* 2.7 ± 2.4*
C 1.7 ± 1.2 0.5 ± 0.6 0.7 ± 0.8 0.6 ± 0.7 0.6 ± 0.9
4 A 8.3 ± 3.4* 0.6 ± 0.9 0.6 ± 0.9 0.5 ± 0.9 0.1 ± 0.5
B 2.1 ± 2.4 7.9 ± 1.6* 4.5 ± 3.7* 3.4 ± 3.2* 2.5 ± 1.9*
C 1.4 ± 2.0 0.9 ± 1.6 0.9 ± 1.8 0.7 ± 1.6 0.2 ± 1.0
5 A 9.3 ± 3.6* 0.8 ± 1.6 0.8 ± 1.5 0.6 ± 1.4 0.2 ± 0.8
B 2.0 ± 2.0 6.5 ± 2.8* 5.8 ± 1.4* 3.7 ± 3.0* 1.3 ± 1.9*
C 1.3 ± 1.7 1.1 ± 1.6 0.8 ± 1.5 0.6 ± 1.4 0.2 ± 0.9
Total A 7.6 ± 3.3* 0.6 ± 1.0 1.0 ± 1.2 0.7 ± 1.0 0.1 ± 0.5
B 2.1 ± 1.7 7.0 ± 3.7* 4.8 ± 2.8* 3.5 ± 2.8* 1.9 ± 1.8*
C 1.3 ± 1.5 0.8 ± 1.2 0.9 ± 1.3 0.6 ± 1.2 0.2 ± 0.7
Values are expressed as percentages (mean ± standard deviation). Data of zones A, B, and C were analyzed in each case. Each section was divided into zones
A, B, and C for evaluation of pathologic heterogeneity. Total is average of five specimens.
*P < .05 versus other two zones.
PCNA, Proliferating cell nuclear antigen; LCA, leukocyte common antigen; vWF, von Willebrand’s factor.
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Fig 1). Ten different fields were randomly selected in each
zone of each section, and the number of nuclei (per 250 
250 m field) was counted with a square reticule with a
10 eyepiece and a 40 objective. Because three sections
were studied in each sample, a total of 30 fields was
counted for each zone.
Cell replication and cellular composition. Paraffin
sections also were analyzed with immunohistochemical
examination. The sections were blocked with 3% hydro-
gen peroxide and preincubated in 1% rabbit serum for 30
minutes, and then the primary antibody was applied at the
appropriate dilution overnight at 4°C. Subsequently, a
biotinylated antimouse or antirabbit secondary antibody
(Signet, Dedham, Mass) was applied for 30 minutes at
room temperature, followed by application of an ABC
Elite kit (Vector Laboratories, Burlingame, Calif) and
counterstaining with hematoxylin. For determination of
cell replication in the arterial wall, a mouse monoclonal
antibody against PCNA (PC10, DAKO [Carpinteria,
Calif]; 1:100) was used. For evaluation of cellular compo-
sition, the following primary antibodies were used; mouse
monoclonal antibodies against -smooth muscle actin
(1A4, DAKO; 1:50), desmin (D33, DAKO; 1:50),
macrophages (KP1, DAKO; 1:50), leukocyte common
antigen (2B11+PD7/26, DAKO; 1:100), and T lympho-
cytes (UCHL-1, DAKO; 1:100), and rabbit polyclonal
antibody against von Willebrand’s factor (DAKO, 1:100).
In each zone of each cross section, 10 fields were ran-
domly selected as described previously, and both the num-
ber of positively stained cells and the total number of
nuclei in each field were counted. Antigen-positive cell
index was calculated (as a percentage) for each immuno-
stained section as 100  NP/NT (with NP the number of
positively stained cells and NT the total number of nuclei).
Control slides were stained with a matching concentration
of mouse or rabbit nonimmune immunoglobulin G,
instead of the primary antibodies.
Evaluation of matrix components. Proteoglycans
were evaluated with a light microscope with paraffin sec-
tions stained with Alcian blue (pH, 2.5). In Alcian blue
staining, blue-positive areas were considered to be proteo-
glycan rich and blue-negative areas were not. Elastin and
collagen were evaluated with Elastica van Gieson (EVG)
staining. We regarded that black-stained areas were elastin
rich and red-stained areas were collagen rich. 
Statistics. For the exclusion of biased evaluation, a
single student helper performed all cell counting in a
blinded fashion. The results were expressed as the mean ±
the standard deviation. The statistical significance of dif-
ferences between values in zones A, B, and C was evalu-
ated with Kruskal-Wallis test followed by Scheffé test. A P
value of less than .05 was interpreted to denote statistical
significance.
RESULTS
Cell density. For the determination of whether cell
density is dependent on the location in the arterial wall
after stent implantation, cell density was measured in
zones A, B, and C. In all arterial samples examined in this
study, Kruskal-Wallis test detected significant differences
in the data of zones A, B, and C, and Scheffé test revealed
that the cell density of zone A was significantly higher than
that of zone B (Table I). The average of the five specimens
also showed the same results (Table I).
Cell replication. Cell replication in each zone was
assessed with staining for PCNA. PCNA-positive cells
were predominantly located in the inner intima, and scarce
PCNA-positive cells were observed in other parts of the
arterial wall (Fig 2A,B). Similarly, quantitative study
results showed that the PCNA-positive cell index of zone
A was significantly higher than that of zones B and C in all
samples and also in the average of the five specimens. In
contrast, no significant difference in the index was
detected between zones B and C (Table II).
Cellular composition. In all zones of all arterial sam-
ples, most intimal cells were -smooth muscle actin–posi-
tive, and there were few desmin-positive cells in all zones
(data not shown). Leukocyte common antigen–positive
cells, macrophages, and T lymphocytes were observed par-
ticularly around the stent struts (Fig 2C-E), and the anti-
gen-positive cell indexes of these cells were higher in zone
B than in zones A and C (Table II). Further, collection of
von Willebrand’s factor–positive cells was detected around
stent struts (Fig 2F; Table II).
Matrix components. For the determination of the
components of the ECM, Alcian blue and EVG staining
were performed. Alcian blue staining results clearly
showed a positive-blue stain in the inner intima and
around the stent struts, which showed accumulation of
proteoglycan (Fig 3, upper panels). In EVG staining, black
stain in the outer intima was stronger than that in the
Fig 1. Photomicrograph of hematoxylin and eosin staining (6).
Zone A, Inner intima within 250 m from luminal surface; zone
B, area surrounding stent struts within 250 m from strut hole;
zone C, remaining part of intimal layer.
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inner intima, which showed that deposition of elastin was
strong in the outer intima. In contrast, red stain that
reflected collagen accumulation was strong in the inner
intima as compared with that in the outer intima (Fig 3,
lower panels). These findings were consistent in almost all
samples.
DISCUSSION
In this study, we analyzed five whole arterial samples
in which a Palmaz-Schatz stent had been implanted for
chronic vascular occlusive disease, and histologic examina-
tion results revealed heterogenous findings that depended
on the location in the intima, at the same time, which
might suggest a unique combination of mechanisms
inducing in-stent lesion formation. One important finding
was a prolonged increase of cell replication, which was
predominantly observed in the inner intima (zone A). In
the inner intima, cell density was significantly higher than
that around stent struts in all samples, and most intimal
cells were smooth muscle cells (SMCs), which suggests
that an increase of SMC number as the result of prolonged
cell replication plays an important role in lesion formation
of the inner intima. Previous study reported that atherec-
tomy samples, resected from areas of in-stent restenosis of
peripheral arteries, contained extensive foci of hypercellu-
larity composed mainly of SMCs and showed evidence of
ongoing proliferative activity.7 Because directional
atherectomy is performed from the luminal side of the
arterial wall, most atherectomy samples must be obtained
from the inner intima. Thus, these data from atherectomy
samples might support the findings of this study, even
though our results showed low-level cell replication
around stent struts and in the outer intima. Alternatively,
there is also a possibility that the inner intima was a newly
formed lesion as compared with the outer intima. Previous
animal studies with arterial injury models showed that cell
replication was increased in the neointima at the early
phase after injury and then the increased cell replication in
the intima decreased gradually with maturation of the
lesion.2,3 If this concept could be extrapolated to forma-
tion of in-stent lesions, lesion increase caused by cell repli-
cation should progress only in the inner intima, which
could also support the findings of this study.
Experimental stent studies with animal models also
showed an increase of cell replication in the intimal layer
after stent implantation.9,12 Kollum et al9 compared the
time course of cell replication after stent implantation with
that after balloon angioplasty and showed that intimal cell
replication after stent implantation was increased more
and prolonged longer than that after balloon angioplasty,
which indicated the importance of cell replication in in-
stent lesion formation. The same study, however, showed
that cell replication had returned to a low level by 4 weeks
after stent implantation and that cell number in the intima
Fig 2. Photomicrographs of immunohistochemical staining. A, Proliferating cell nuclear antigen (PCNA; 40). B, PCNA
(40). C, Leukocyte common antigen (20). D, Macrophage (20). E, T lymphocyte (20). F, von Willebrand’s factor
(20). Antigen-positive cells stained brown, and sections were counterstained with hematoxylin. Cell replication was measured
with PCNA index. Approximately 8% of lesion cells were PCNA-positive in inner intima (A), and there were few PCNA-
positive cells in outer intima (B). Leukocytes (C), macrophages (D), and T lymphocytes (E) accumulated around stent struts.
Microneovascularization (F) was also observed around stent struts. Arrow indicates microneovascularization.
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decreased after that. In humans, previous studies provided
controversial findings about cell replication in the intima
after stent implantation, as described previously.7,8
Kearney et al7 showed marked and prolonged cell replica-
tion in atherectomy samples resected from in-stent lesions of
peripheral arteries. In detail, 16.7% to 36.0% (mean, 23.9%)
of lesion cells were PCNA-positive in samples from patients
more than 10 months after stenting. To the contrary, Strauss
et al,8 with coronary atherectomy samples, reported low-
level cell replication a few months after stent implantation.
Because the previous studies evaluated only some part of the
whole lesion, there was a possibility that the findings of these
studies did not reflect the true pathogenesis of in-stent
restenosis, which could explain the discrepancy in the
results. Another possibility to explain the discrepancy in the
previous results was difference in responses between periph-
eral artery and coronary artery. This study analyzed whole
arterial samples of peripheral artery and showed relatively
high-level cell replication in the intima even at 7 to 19
months after stent implantation. Some study groups showed
that implantation of a radioactive stent prevented prolifera-
tion of in-stent lesions in animal models.13,14 Because repli-
cating cells are more susceptible to radiation than are
quiescent cells, the results of the radioactive stent study are
consistent with the data of this study.
The finding that the cell replication was observed pre-
dominantly in the inner intima might provide an insight in
the identification of the mitogen(s) promoting cell repli-
cation after stent implantation. Namely, mitogens might
be released around the inner intima. In the cells and sub-
stances around the inner intima, one of the most plausible
sources of mitogen is thrombus adherent to the luminal
surface. It is known that thrombi contain a variety of
potent mitogens for arterial wall SMCs, such as thrombin
and platelet-derived growth factor.15-18 Farb et al19
showed that fibrin and platelet-rich thrombi were associ-
Fig 3. Upper panels are photomicrographs of Alcian blue staining (pH, 2.5; 4). Proteoglycan (blue stain) was stained around
stent struts and in inner intima, and photomicrographs of patient 4 show deposition of proteoglycan only around stent strut.
Lower panels are photomicrographs of Elastica van Gieson staining (4). Note accumulation of elastin in outer intima (black
stain) and collagen deposition in inner intima (red stain). *Stent strut. Pt, patient number in Table I; arrowhead, proteogly-
can accumulation; arrow, boundary between red-stained and black-stained areas; I, intima.
ated with the stent struts, especially early after stenting.
Further, another study showed organized thrombus in the
chronic phase after stent implantation.7
Another important feature is accumulation of ECM,
which was mainly observed around the stent struts (zone
B) and in the remaining part of the outer intima (zone C).
In the same area, this study showed lower cell density or
lower cell replication as compared with the inner intima,
which suggests that matrix accumulation was more critical
than the increase of cell number because of cell replica-
tion. Previous studies with animal models evaluated the
responses to balloon angioplasty injury of arteries with
preexisting intimal lesions and showed similar findings in
the intima after balloon angioplasty; intimal size was
increased in the late phase after balloon angioplasty, and
the increase of intimal size was associated with matrix
accumulation in the intima and not with intimal cell repli-
cation observed immediately after balloon angioplasty.20-
22 These studies, however, reported that the increase of
collagen and elastin was more important for matrix accu-
mulation than proteoglycans.21,22 Because this study
showed deposition of proteoglycans in the matrix-accu-
mulated area, there was a discrepancy with the previous
studies described. One possible cause for the discrepancy
might be inflammatory reactions around stent struts.
Immunohistologic examination in this study showed sig-
nificant infiltration of leukocytes, including macrophages
and T-lymphocytes, in zone B, and previous studies also
described inflammatory cell infiltration around stent
struts.9,10 We considered that such inflammatory infiltra-
tion was a response to the stent strut itself or to thrombus
deposited around stent struts. Macrophages and other
inflammatory cells are known to release humoral factors in
certain conditions and stimulate other cells to secrete pro-
teoglycans, and macrophages themselves can secrete pro-
teoglycans.23,24 Thus, significant accumulation of
proteoglycans around stent struts might be reasonable
after stent implantation, although this mechanism cannot
explain why proteoglycans were significantly deposited
also in the inner intima (zone A), because no significant
infiltration of inflammatory cells was observed in this
zone. Although we are now unsure which factor(s) pro-
moted the accumulation of proteoglycans in the inner
intima, there is a possibility that an unknown factor is
secreted at the luminal surface. An experimental study
with an arterial cuff model showed that a cuff, placed
around the arterial adventitia, induced adhesion of leuko-
cytes to the luminal surface as an inflammatory response
to the foreign body.25,26 Because a stent is also a foreign
body, we think that leukocytes in the blood vessel possibly
adhere to the surface of the intimal lesion, even though
the stent is completely covered by neointima.
Finally, we have to address some issues in this study.
The most crucial issue is the small number of sample cases
with different backgrounds. Further, the large intraspeci-
men standard deviation in each counting is also crucial.
However, in this study, we could detect some significant
findings that suggest the mechanisms of in-stent lesion
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formation. In the future, we plan to add new samples to
this series to reinforce the data of this study.
In summary, analysis of five resected arterial samples
with an implanted stent showed two different histopatho-
logic findings in different parts of the same arteries. One
result was a prolonged increase of cell replication in the
inner intima, and the other was accumulation of ECM
around stent struts and in other parts of the intima. These
heterogenous findings suggest that these two mechanisms
contribute to the formation of in-stent intimal lesions after
stent implantation.
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CORRECTION
In: “A clinical comparison of pneumatic compression devices: The basis for selection” (Proctor MC,
Greenfield LJ, Wakefield TW, Zajkowski PJ. J Vasc Surg 2001;34:459-64).
The abstract contains an error. The last line of the “Results” section of the abstract should read “Compression
device W, with calf and thigh sleeves, achieved the best overall ranking largely because of high scores for patient
and nurse satisfaction.”
